KINCARE HEALTH SOLUTIONS LTD

Company Registration Number:
SC666992 (Scotland)

Unaudited statutory accounts for the year ended 31 July 2025

Period of accounts

Start date: 1 August 2024

End date: 31 July 2025

KINCARE HEALTH SOLUTIONS LTD

Contents of the Financial Statements

for the Period Ended 31 July 2025

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

KINCARE HEALTH SOLUTIONS LTD

Directors' report period ended 31 July 2025

The directors present their report with the financial statements of the company for the period ended 31 July 2025

Principal activities of the company

The director presents the report and the unaudited abridged financial statements of the company for the year ended 31 July 2025. Directors The director who served the company during the year was as follows: Joyce Mudzungudzi Ms Joyce Mudzungudzi Employment of disabled persons Small company provisions This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption. This report was approved by the board of directors on 13 June 2025 and signed on behalf of the board by: Joyce Mudzungudzi



Directors

The director shown below has held office during the whole of the period from
1 August 2024 to 31 July 2025

Joyce Mudzungudzi


Secretary Blessing Mudzungudzi

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
4 October 2025

And signed on behalf of the board by:
Name: Joyce Mudzungudzi
Status: Director

KINCARE HEALTH SOLUTIONS LTD

Profit And Loss Account

for the Period Ended 31 July 2025

2025 2024


£

£
Turnover: 1,242,799 1,042,394
Cost of sales: ( 825,568 ) ( 714,383 )
Gross profit(or loss): 417,231 328,011
Administrative expenses: ( 334,612 ) ( 232,509 )
Operating profit(or loss): 82,619 95,502
Interest receivable and similar income: 62 17
Profit(or loss) before tax: 82,681 95,519
Profit(or loss) for the financial year: 82,681 95,519

KINCARE HEALTH SOLUTIONS LTD

Balance sheet

As at 31 July 2025

Notes 2025 2024


£

£
Called up share capital not paid: 1 1
Fixed assets
Tangible assets: 3 27,220 43,073
Investments: 4 2,743
Total fixed assets: 29,963 43,073
Current assets
Debtors: 5 330,202 251,278
Cash at bank and in hand: 20,694 18,833
Total current assets: 350,896 270,111
Creditors: amounts falling due within one year: 6 ( 172,856 ) ( 174,274 )
Net current assets (liabilities): 178,040 95,837
Total assets less current liabilities: 208,004 138,911
Creditors: amounts falling due after more than one year: 7 ( 45,380 ) ( 58,968 )
Total net assets (liabilities): 162,624 79,943
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 162,623 79,942
Total Shareholders' funds: 162,624 79,943

The notes form part of these financial statements

KINCARE HEALTH SOLUTIONS LTD

Balance sheet statements

For the year ending 31 July 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 4 October 2025
and signed on behalf of the board by:

Name: Joyce Mudzungudzi
Status: Director

The notes form part of these financial statements

KINCARE HEALTH SOLUTIONS LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover is measured at the fair value of the consideration received or receivable for goods supplied, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer, usually on despatch of the goods; the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

    Tangible fixed assets depreciation policy

    Tangible assets are initially measured at cost, and are subsequently measured at cost less any accumulated depreciation and accumulated impairment losses or at a revalued amount. Any tangible assets carried at a revalued amount are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation is recognised in other comprehensive income and accumulated in capital and reserves. However, the increase is recognised in profit or loss to the extent that it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves. If a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess is recognised in profit or loss.

    Other accounting policies

    Fixed asset investments Investments in subsidiaries, associates and joint ventures accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in subsidiaries, associates and joint ventures accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income or profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition. Other fixed asset investments which are listed are measured at fair value with changes in fair value being recognised in profit or loss. All other Investments held as fixed assets are initially recorded at cost, and are subsequently stated at cost less any accumulated impairment losses.

KINCARE HEALTH SOLUTIONS LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

  • 2. Employees

    2025 2024
    Average number of employees during the period 45 25

KINCARE HEALTH SOLUTIONS LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 August 2024 740 63,113 63,853
Additions
Disposals
Revaluations
Transfers
At 31 July 2025 740 63,113 63,853
Depreciation
At 1 August 2024 42 20,738 20,780
Charge for year 21 15,832 15,853
On disposals
Other adjustments
At 31 July 2025 63 36,570 36,633
Net book value
At 31 July 2025 677 26,543 27,220
At 31 July 2024 698 42,375 43,073

KINCARE HEALTH SOLUTIONS LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

4. Fixed assets investments note

Investments in subsidiaries, associates and joint ventures accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in subsidiaries, associates and joint ventures accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income or profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition. Other fixed asset investments which are listed are measured at fair value with changes in fair value being recognised in profit or loss. All other Investments held as fixed assets are initially recorded at cost, and are subsequently stated at cost less any accumulated impairment losses.

KINCARE HEALTH SOLUTIONS LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

5. Debtors

2025 2024
£ £
Trade debtors 114,494 4,744
Prepayments and accrued income 28,918 17,221
Other debtors 186,790 229,313
Total 330,202 251,278

KINCARE HEALTH SOLUTIONS LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

6. Creditors: amounts falling due within one year note

2025 2024
£ £
Taxation and social security 85,473 69,641
Accruals and deferred income 7,160 0
Other creditors 80,223 104,633
Total 172,856 174,274

KINCARE HEALTH SOLUTIONS LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

7. Creditors: amounts falling due after more than one year note

2025 2024
£ £
Amounts due under finance leases and hire purchase contracts 45,380 58,968
Total 45,380 58,968

KINCARE HEALTH SOLUTIONS LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

8. Loans to directors

Name of director receiving advance or credit: Joyce Mudzungudzi
Description of the transaction:
Capital Injection
£
Balance at 31 July 2024 67,967
Advances or credits made:
Advances or credits repaid: 1,000
Balance at 31 July 2025 66,967